Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the browsers below.

Internet Explorer 10, Firefox, Chrome, or Safari.

Life extending technology

August 21, 2018 / Source: The Record

Kitchener startup's 'life extending' technology helps researchers study disease and develop new medicines.

KITCHENER — Ryan Denomme pursues cutting edge science from inside an old factory building where his grandmother used to work.

Denomme is the co-founder and chief executive officer of Nicoya Lifesciences, which recently launched the second version of its desktop device that measures interactions between some of the most important building blocks in the human body — proteins.

Proteins are one or two nanometres wide, and responsible for building and operating human organs. A nanometre is one-billionth of a metre. Seeing how proteins interact with other proteins is critical to understanding how a disease progresses, and whether a new medication is effective.

Last month, Nicoya launched a new version of the sensitive and complex device for measuring those interactions. Earlier this year, it raised $2 million in a second round of financing.

The startup, founded in 2012, now employs 30 people who work out of second-floor offices inside the former Boehmer Box building at 283 Duke St. W.